Hematocrit Stabilized in Polycythemia Vera Treated With Novel Hepcidin Mimetic

(MedPage Today) -- SAN DIEGO -- A novel therapy for polycythemia vera (PCV) maintained stable hematocrit levels for as long as 2.5 years and significantly reduced use of phlebotomy, a small randomized trial showed. The hepcidin mimetic rusfertide...
Source: MedPage Today Hematology/Oncology - Category: Hematology Source Type: news